Musgrave, W. and H. West Suffolk (1715). Guilhelmi Musgrave. De arthritide symptomatica dissertatio. Genevae, apud fratres de Tournes.
|
Musgrave, W., C. Yeo, et al. (1703). De arthritide symptomatica dissertatio. Exoniae; Londini quoque prostant venales., Typis Farleianis. Sumptibus Yeo & Bishop, sosiorum [sic].
|
Musgrave, W., R. Mead, et al. (1710). Guilhelmus Musgrave M.D: De arthritide anomala, sive, Interna dissertatio; ut et Richardus Mead. De imperio solis ac lunae in corpora humana, & morbis inde oriundis. Amstelaedami [Amsterdam], apud Wetstenios.
|
Musgrave, W., S. Farley, et al. (1707). De arthritide anomala, sive interna, dissertatio. Exoniae; Londini quoque veneunt., Typis S. Farley, & J. Bliss; sumptibus Philippi Bishop.
|
Myers, A. and T. University of Newcastle upon (2003). The recurrence of different patterns of psoriatic arthritis within sibships. Newcastle upon Tyne, University of Newcastle upon Tyne.
|
Namey, T. C. (1990). Rheumatic disease clinics of North America. Philadelphia; London, Saunders.
|
National Arthritis Foundation of, S. and R. Singapore Society of Immunology and (1989). Systemic lupus erythematosus: 2nd International conference: Papers. Tokyo, Professional Postgraduate Services.
|
National Diabetes Data, G. (1985). Diabetes in America: diabetes data compiled 1984. Bethesda, National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases.
|
National Diabetes Information, C. (1980). General information about diabetes: selected annotations. Washington, D.C., Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Arthritis, Metabolism, and Digestive Diseases.
|
National Diabetes Information, C. and D. D. a. K. D. National Institute of Arthritis (1981). State and Federal assistance: resource directory for people with diabetes. Bethesda, Md., Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases.
|
National Diabetes Information, C. and M. a. D. D. National Institute of Arthritis (1980). Diabetes and aging: selected annotations. [Washington, D.C.], National Institute of Arthritis, Metabolism, and Digestive Diseases.
|
National Health Education, C. (1955). Facts on the major killing and crippling diseases in the United States today: heart diseases, cancer, mental illness, arthritis, blindness, neurological diseases, and other health problems, New York.
|
National Institute for Clinical, E. (2001). Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for esteoarthritis and rheumatoid arthritis. London, National Institute for Clincal Excellence.
|
National Institute for Clinical, E. (2001). Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis. London, National Institute for Clinical Excellence.
|
National Institute for Clinical, E. (2001). Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, melxicam and etodolac for osteoarthritis and rheumatoid arthritis, National Institute for Clinical Excellence.
|
National Institute for Clinical, E. (2003). Anakinra for rheumatoid arthritis: quick reference guide. London, National Institute for Clinical Excellence.
|
National Institute for Clinical, E. (2005). Artificial metacarpophalangeal and interphalangeal joint replacement for end-stage arthritis. London, National Institute for Clinical Excellence.
|
National Institute for Clinical, E. and S. Great Britain. National Health (2003). Anakinra for rheumatoid arthritis. London, National Institute for Clinical Excellence.
|
National Institute for Clinical, E. and S. National Health (2001). Guidance on the use of cyclo-oxygenase (cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthitis and rheumatoid arthritis. London, National Institute for Clinical Excellence.
|
National Institute for Clinical, E. and S. National Health (2002). Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. London, National Institute for Clinical Excellence.
|
National Institute for Clinical, E. and S. National Health (2002). Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis. London, National Institute for Clinical Excellence.
|
National Institute for Clinical, E. and S. National Health (2002). Guidance on the use of metal on metal hip resurfacing arthroplasty. London, National Institute for Clinical Excellence.
|
National Institute for Disability and Rehabilitation, R. (1987). Current research and future directions in rehabilitation: Conference on arthritis rehabilitation research: Papers. Canada, Journal of rheumatology publishing co.
|
National Institute of Arthritis and Metabolic Diseases Artificial Kidney Program Annual Contractors, C. (1972). Proceedings - Annual Contractors' Conference of the Artificial Kidney Program of the National Institute of Arthritis and Metabolic Diseases. [Washington, D.C.?], DHEW.
|
National Institute of Arthritis and Metabolic Diseases. Artificial Kidney-Chronic Uremia, P., M. a. D. D. A. K.-C. U. P. National Institute of Arthritis, et al. (1975). Artificial kidney bibliography. Bethesda, Md., U.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes Health.
|
National Institute of Arthritis and Metabolic, D. (1955). What progress against arthritis and metabolic diseases? summary reports. New York, [National Health Education Committee?].
|
National Institute of Arthritis and Metabolic, D. (1971). Endocrinology index.
|
National Institute of Arthritis and Metabolic, D. and F. National Cystic Fibrosis Research (1964). Research on pathogenesis of cystic fibrosis of the pancreas (mucoviscidosis). n.p., n.pub.
|
National Institute of Arthritis and Metabolic, D., F. Excerpta Medica, et al. (1970). Arthritis and rheumatic diseases abstracts. Bethesda, Md, National Institute of Arthritis and Metabolic Diseases.
|
National Institute of Arthritis and Musculoskeletal and Skin, D. (1994). The epidemiology of skin diseases: Workshop: Papers and extended abstracts, Elsevier Science Publishers.
|
National Institute of Arthritis, D. a. D. a. K. D. (1985). The NIADDK program project grant: administrative guidelines. Bethesda, National Institutes of Health, National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases.
|
National Institute of Arthritis, M. a. D. D. (1979). Kidney disease and nephrology index. Bethesda, Md, National Institute of Arthritis, Metabolism and Digestive Diseases.
|
National Institute of Arthritis, M. a. D. D. A. K. C. U. P. (1974). Evaluation of membranes for hemodialyzers: report of the Membrane Evaluation Study Group for the Artificial Kidney-Chronic Uremia Program. Bethesda, Md, National Institute of Arthritis, Metabolism and Digestive Diseases.
|
National Institute of Arthritis, M. a. D. D. A. K.-C. U. P. A. C. C. (1973). Annual Contractors' Conference. Artificial Kidney-Chronic Uremia Program. National Institute of Arthritis, Metabolism and Digestive Diseases. [Washington, D.C.?], DHEW.
|
National Institute of Arthritis, M. a. D. D. and M. National Library of (1979). Index of dermatology. Bethesda, Md., The Institute.
|
National Institute of Arthritis, M. a. D. D. O. o. t. A. D. f. A. B. a. S. D. (1978). Progress against the rheumatic diseases (1967-1977): a report to the Senate Committee on Appropriations. Washington, D.C., Govt Print Off.
|
National institute of arthritis, m. a. d. d., h. s. a. m. h. a. N. P. center for disease control, et al. (1972). A selected bibliography on East-Asian foods and nutrition arranged according to subject matter and area. Bethesda, Md, U.S. Dept. of Health, Education and Welfare.
|
National institute of arthritis, m. a. d. d., h. s. a. m. h. a. N. P. center for disease control, et al. (1972). Food composition table for use in East Asia. Bethesda, Md, U.S. Dept. of Health, Education, and Welfare.
|
National Institute of Diabetes and Digestive and Kidney, D. and D. National Institute of Arthritis and Musculoskeletal and Skin (1995). Les hormones anabolisantes de l'os: recherches fondamentales et potentiel therapeutique: Atelier: Abstracts. Paris, Les Editions de Medecine Pratique.
|
National Institute on, A. (1985). Age page: arthritis advice. [Washington], US Department of Health and Human Services, Public Health Service, National Institutes of Health.
|